InfuSystem Stock: Margin Expansion And Growth Strategy To Drive Strong Gains

InfuSystem (INFU) is poised for strong growth with rising profits, margin gains, and expansion in patient services. Read here ...
MyChesCo on MSN

Incyte and Enable Injections Join Forces to Advance At-Home Cancer Treatments

Incyte (NASDAQ: INCY) and Enable Injections have formed a strategic partnership to co-develop and commercialize targeted cancer therapies using Enable’s enFuse® On-Body Delivery System, ...

3 Biopharma Names I Am Buying After Avadel's Buyout

Biotech and biopharma M&A activity has surged in recent weeks, sparking a strong sector rally and renewed optimism. Learn why stocks like AVDL look attractive.
BioSpace

Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V. (ustekinumab), a Biosimilar to Stelara®

TORONTO and BENGALURU, India, Oct. 23, 2025 /CNW/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), today announced ...
Frontiers

Case Report: Effect of preventive intravenous iron infusion on postoperative hemoglobin levels in a female patient with latent iron deficiency anemia before total hip arthroplasty

This article presents a case of orthopedic treatment of a 51-year-old patient with latent iron deficiency anaemia and congenital dysplasia of both hip joints. The patient was admitted with complaints ...